BR9400600A - Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos - Google Patents
Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processosInfo
- Publication number
- BR9400600A BR9400600A BR9400600A BR9400600A BR9400600A BR 9400600 A BR9400600 A BR 9400600A BR 9400600 A BR9400600 A BR 9400600A BR 9400600 A BR9400600 A BR 9400600A BR 9400600 A BR9400600 A BR 9400600A
- Authority
- BR
- Brazil
- Prior art keywords
- processes
- cerevisae
- glycosylphosphatidylinositol
- gpi
- yeasts
- Prior art date
Links
- 229930004094 glycosylphosphatidylinositol Natural products 0.000 title 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 210000004027 cell Anatomy 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000001963 growth medium Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 239000002773 nucleotide Substances 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 210000005253 yeast cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6481—Phosphoglycerides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
- C07K2319/912—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation containing a GPI (phosphatidyl-inositol glycane) anchor
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9400600A BR9400600A (pt) | 1994-02-17 | 1994-02-17 | Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos |
PCT/BR1995/000010 WO1995022614A1 (fr) | 1994-02-17 | 1995-02-16 | Production de proteines recombinees ancrees par glycosylphosphatidylinositol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9400600A BR9400600A (pt) | 1994-02-17 | 1994-02-17 | Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9400600A true BR9400600A (pt) | 1995-10-24 |
Family
ID=4058332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9400600A BR9400600A (pt) | 1994-02-17 | 1994-02-17 | Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos |
Country Status (2)
Country | Link |
---|---|
BR (1) | BR9400600A (fr) |
WO (1) | WO1995022614A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP940432B1 (en) * | 1994-08-05 | 2003-10-31 | Pliva Pharm & Chem Works | Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin |
US6113917A (en) * | 1995-04-25 | 2000-09-05 | Rmf Dictagene S.A. | Modified polypeptides for enhanced immunogenicity |
US7312062B2 (en) | 1998-11-27 | 2007-12-25 | Novozymes A/S | Lipolytic enzyme variants |
ATE328605T1 (de) | 2000-03-24 | 2006-06-15 | Genentech Inc | Verwendung von insulin zur behandlung von knorpelkrankheiten |
ATE365224T1 (de) * | 2002-11-22 | 2007-07-15 | Eisai R&D Man Co Ltd | Verfahren zum screening nach verbindungen, die die enzymatische aktivität des gwt1 genproduktes hemmen |
ATE479760T1 (de) * | 2004-03-24 | 2010-09-15 | Domantis Ltd | Universelles signalpeptid gas1 |
WO2007128766A1 (fr) * | 2006-05-10 | 2007-11-15 | Novozymes A/S | Procedes d'extraction de composants d'une culture de cellules de levure |
WO2008100816A2 (fr) * | 2007-02-09 | 2008-08-21 | Medimmune, Llc | Présentation d'anticorps |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA808097B (en) * | 1980-12-29 | 1982-01-27 | Lilly Co Eli | Novel insulin formulations |
US5109113A (en) * | 1986-05-02 | 1992-04-28 | Genentech, Inc. | Membrane anchor fusion polypeptides |
WO1989005825A1 (fr) * | 1987-12-22 | 1989-06-29 | Immunex Corporation | EXPRESSION D'ANTIGENES DE PROTEINES 18/16,6 et 15,2 kD RECOMBINANTES DE MYCOBACTERIUM LEPRAE |
US5223394A (en) * | 1989-04-10 | 1993-06-29 | Biogen, Inc. | Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence |
WO1992001715A1 (fr) * | 1990-07-19 | 1992-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | Proteines dimeres solubles de surface cellulaire |
EP0477739A3 (en) * | 1990-09-27 | 1992-12-09 | F. Hoffmann-La Roche Ag | Glycosyl-phosphatidylinositol-specific phospholipase d |
US5573779A (en) * | 1992-04-10 | 1996-11-12 | Hisamitsu Pharmaceutical Co., Inc. | Liposome composition |
EP1018343A1 (fr) * | 1992-07-10 | 2000-07-12 | University Of British Columbia | Utilisation de p97 et des protéines liant le fer comme agents diagnostiques et thérapeutiques |
-
1994
- 1994-02-17 BR BR9400600A patent/BR9400600A/pt not_active Application Discontinuation
-
1995
- 1995-02-16 WO PCT/BR1995/000010 patent/WO1995022614A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995022614A1 (fr) | 1995-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE290589T1 (de) | Rekombinante hefe zur effizienten fermentation von glucose und xylose | |
BR9507678A (pt) | Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura | |
EP0945515A3 (fr) | Production de protéines par recombinaison homologue | |
BR8200191A (pt) | Celula viva renina preprorrenina prorrenina processo para obter expressao de preporrenina prorrenina e renina gene de prorrenina preprorrenina e renina e coli material dna recombinador saccharomyces cerevisiae polipetidio processo para exprimir um gene | |
BR8106137A (pt) | Polipeptidio sequencia de dna veiculo de expressao microbiiana copiavel plasmidio microorganismo composicao extrato bacteriano composicao farmaceutica cultura de celulas microbianas aplicacao de um interferon e processos de producaode alguns desses itens | |
ES2255281T3 (es) | Sobreexpresion de genes de fitasa en sistmas de levadura. | |
FI885679A (fi) | Samuttryckning i eukariotiska celler. | |
IE840258L (en) | Expression of gene products. | |
BR9400600A (pt) | Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos | |
WO1999025878A3 (fr) | Procedes pour moduler et identifier la senescence cellulaire | |
AU621810B2 (en) | Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for fermentation processes | |
GB1170929A (en) | Antirival Nucleic Acids. | |
AU551487B2 (en) | Culturing human cells in algae extract | |
CA2031286A1 (fr) | Methodes d'inactivation biologique des acides nucleiques | |
CA2390104A1 (fr) | Procede de transfert de substances moleculaires au moyen de proteines procaryotiques liant des acides nucleiques | |
AU586874B2 (en) | Invasive microorganisms | |
WO2000006713A3 (fr) | Techniques et produits de recombinaison relatifs a une expression de proteine | |
AU7137996A (en) | Materials and methods relating to the transfer of nucleic acid into quiescent cells | |
AU6464699A (en) | Labeling, immobilisation, enrichment, purification and detection of cells using specific domains that bind to the cell walls (cbd) of proteins binding to the drawn cell walls of viruses, bacteria or eukaryotic cells | |
AU6113098A (en) | Compositions for treatment of disorders involving programmed cell death | |
WO2001079525A3 (fr) | Acides nucleiques et poypeptides purifies et isoles cotransporteurs de chlorure de potassium | |
AU1948788A (en) | Expression of immunologically active proteins of human b-lymphotropic virus | |
PT801682E (pt) | Processo para a producao de proteinas | |
FR2603040B1 (fr) | Proteine, sequence d'adn, poxvirus, cellules et leur procede de culture, ainsi que les compositions pharmaceutiques les contenant, utiles dans la prevention de la schistosomose | |
WO2000037682A8 (fr) | Procede permettant d'accroitre l'expression d'un gene etranger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C12P 7/64 (2006.01), C07K 14/35 (2006.0 |